Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof

Details for Australian Patent Application No. 2001253471 (hide)

Owner The Penn State Research Foundation Medical University of South Carolina

Inventors Dolan, Joseph; Schmidt, Michael G; Norris, James S.; Westwater, Caroline; Pan, Weihua; Hoel, Brian; Schofield, David; Clawson, Gary A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001253471

PCT Pub. Number WO01/79524

Priority 60/251,810 07.12.00 US; 09/548,449 13.04.00 US

Filing date 13 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 26 July 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/12 (2006.01) Drugs for dermatological disorders

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

26 July 2007 Application Accepted

  Published as AU-B-2001253471

22 November 2007 Standard Patent Sealed

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253472

2001253470